Search research articles
Contact Us
Filters
Showing results (141-150 of 173) with videos related to
Page
of 18
Sort By:
Journal of Cancer
|
June 23, 2017
Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer
Shuwei Li, Lisheng Xie, Lei He, et al.
Scientific Reports
|
October 23, 2020
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
Li Ma, Yunzhe Mi, Shude Cui, et al.
Medicine
|
May 9, 2020
Opening label, dynamic prospective cohort study on the small focus less than 1.0 cm shown by type B ultrasound in breast
Aiping Shi, Yi Dong, Xinpeng Xie, et al.
Journal of Gastroenterology
|
March 30, 2019
Genetic variants in RPA1 associated with the response to oxaliplatin-based chemotherapy in colorectal cancer
Shuwei Li, Kaili Xu, Dongying Gu, et al.
Biochemical Pharmacology
|
December 22, 2024
CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p/TFDP2 axis
Dexian Wei, Fan Zhang, Min Li, et al.
Scientific Reports
|
January 9, 2021
Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin
Weifang Liu, Wei Chen, Xiuxiang Zhang, et al.
Breast Cancer Research : BCR
|
September 14, 2018
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Pin Gao, Xiang Wang, Ying Jin, et al.
Frontiers in Oncology
|
June 27, 2022
Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
Dechuang Jiao, Benlong Yang, Jiajian Chen, et al.
The Oncologist
|
June 12, 2025
Pegylated liposomal doxorubicin + cyclophosphamide followed by taxane as adjuvant therapy for early-stage breast cancer: a randomized controlled trial
Lichen Tang, Min He, Cuizhi Geng, et al.
International Journal of Clinical Oncology
|
May 7, 2026
The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study
Tao Huang, Zhimin Fan, Yongsheng Wang, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 173) with videos related to
Sort By:
Page
of 18
Journal of Cancer
|
June 23, 2017
Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer
Shuwei Li, Lisheng Xie, Lei He, et al.
Scientific Reports
|
October 23, 2020
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
Li Ma, Yunzhe Mi, Shude Cui, et al.
Medicine
|
May 9, 2020
Opening label, dynamic prospective cohort study on the small focus less than 1.0 cm shown by type B ultrasound in breast
Aiping Shi, Yi Dong, Xinpeng Xie, et al.
Journal of Gastroenterology
|
March 30, 2019
Genetic variants in RPA1 associated with the response to oxaliplatin-based chemotherapy in colorectal cancer
Shuwei Li, Kaili Xu, Dongying Gu, et al.
Biochemical Pharmacology
|
December 22, 2024
CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p/TFDP2 axis
Dexian Wei, Fan Zhang, Min Li, et al.
Scientific Reports
|
January 9, 2021
Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin
Weifang Liu, Wei Chen, Xiuxiang Zhang, et al.
Breast Cancer Research : BCR
|
September 14, 2018
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Pin Gao, Xiang Wang, Ying Jin, et al.
Frontiers in Oncology
|
June 27, 2022
Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
Dechuang Jiao, Benlong Yang, Jiajian Chen, et al.
The Oncologist
|
June 12, 2025
Pegylated liposomal doxorubicin + cyclophosphamide followed by taxane as adjuvant therapy for early-stage breast cancer: a randomized controlled trial
Lichen Tang, Min He, Cuizhi Geng, et al.
International Journal of Clinical Oncology
|
May 7, 2026
The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study
Tao Huang, Zhimin Fan, Yongsheng Wang, et al.
Page
of 18